相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual
Simona Pichini et al.
TALANTA (2020)
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
Angela Gasse et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2020)
Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
Lourdes Poyatos et al.
MEDICINA-LITHUANIA (2020)
Investigation of phase II metabolism of 11-hydroxy-Delta-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Delta-9-tetrahydrocannabinol-glucuronide
Christoph Hassenberg et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2020)
Phytocannabinoid drug-drug interactions and their clinical implications
Daniela Amaral Silva et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Beneficial and deleterious effects of cannabinoids in the brain: the case of ultra-low dose THC
Yosef Sarne
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation
Roger Hudson et al.
JOURNAL OF NEUROSCIENCE (2019)
LC-MS/MS quantitation of phytocannabinoids and their metabolites in biological matrices
Wessam H. Abd-Elsalam et al.
TALANTA (2019)
Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder
Mariah M. Wu et al.
BRAIN RESEARCH (2019)
The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications
Yuli Qian et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study
Gil Bar-Sela et al.
INTEGRATIVE CANCER THERAPIES (2019)
8β-OH-THC and 8β,11-diOH-THC-minor metabolites with major informative value?
Angela Gasse et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2018)
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study
Lanfranco Pellesi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Review of animal studies on the cardiovascular effects of caffeine
Leslie A. Beyer et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol
Yosef Sarne et al.
NEUROBIOLOGY OF AGING (2018)
Prediction of CYP2D6 phenotype from genotype across world populations
Andrea Gaedigk et al.
GENETICS IN MEDICINE (2017)
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes
Ryan Vandrey et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2017)
HIV-Associated Neurocognitive Disorders: A Global Perspective
Rowan Saloner et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2017)
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
Andras Bilkei-Gorzo et al.
NATURE MEDICINE (2017)
Sex differences in the subjective effects of oral Δ9-THC in cannabis users
Jessica S. Fogel et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics
Melissa E. Badowski
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Bioavailability of cyanide after consumption of a single meal of foods containing high levels of cyanogenic glycosides: a crossover study in humans
Klaus Abraham et al.
ARCHIVES OF TOXICOLOGY (2016)
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes
Incoronata Galasso et al.
Frontiers in Plant Science (2016)
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
Rebecca L. Hartman et al.
CLINICAL CHEMISTRY (2015)
Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients
Paolo Palatini et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
Amir I. A. Ahmed et al.
PSYCHOPHARMACOLOGY (2015)
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
Dirk W. Lachenmeier et al.
SCIENTIFIC REPORTS (2015)
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stephen M. Stout et al.
DRUG METABOLISM REVIEWS (2014)
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial
Amir I. A. Ahmed et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Controversies in HIV-associated neurocognitive disorders
Sam Nightingale et al.
LANCET NEUROLOGY (2014)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Raymond J. M. Niesink et al.
Frontiers in Psychiatry (2013)
Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects
Linda E. Klumpers et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Interaction between cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
Antonio Waldo Zuardi et al.
PSYCHOPHARMACOLOGY (2012)
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
Satoshi Yamaori et al.
LIFE SCIENCES (2011)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Biomarkers for the effects of cannabis and THC in healthy volunteers
Lineke Zuurman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Interindividual Variation in the Pharmacokinetics of Δ9-Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9
C. Sachse-Seeboth et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
Anna Mazur et al.
DRUG METABOLISM AND DISPOSITION (2009)
CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension
Paolo Palatini et al.
JOURNAL OF HYPERTENSION (2009)
Tolerability and effects of oral Δ9-tetrahydrocannabinol in older adolescents with marijuana use disorders
Kevin M. Gray et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Developing limits for driving under cannabis
Franjo Grotenhermen et al.
ADDICTION (2007)
Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes
Kazuhito Watanabe et al.
LIFE SCIENCES (2007)
History of cannabis and its preparations in saga, science, and sobriquet
Ethan B. Russo
CHEMISTRY & BIODIVERSITY (2007)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Cognition and motor control as a function of Δ9-THC concentration in serum and oral fluid:: Limits of impairment
J. G. Ramaekers et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Δ9-Tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids
Robert S. Goodivin et al.
THERAPEUTIC DRUG MONITORING (2006)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Toxicokinetics of drugs of abuse: Current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine
HH Maurer et al.
THERAPEUTIC DRUG MONITORING (2006)
Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract
T Nadulski et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2005)
Isolation of Δ9-THCA-A from hemp and analytical aspects concerning the determination of Δ9-THC in cannabis products
FE Dussy et al.
FORENSIC SCIENCE INTERNATIONAL (2005)
The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes
OH Drummer et al.
ACCIDENT ANALYSIS AND PREVENTION (2004)
Cytochrome P4502C9 polymorphisms: a comprehensive review of the in-vitro and human data
CR Lee et al.
PHARMACOGENETICS (2002)
Δ9-THC, 11-OH-Δ9-THC and Δ9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people
C Giroud et al.
FORENSIC SCIENCE INTERNATIONAL (2001)
Evaluating the impact of hemp food consumption on workplace drug tests
G Leson et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2001)
Consumption and quantitation of Δ9-tetrahydrocannabinol in commercially available hemp seed oil products
TZ Bosy et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2000)
High-performance liquid chromatographic determination of Δ9-tetrahydrocannabinol and the corresponding acid in hemp containing foods with special regard to the fluorescence properties of Δ9-tetrahydrocannabinol
O Zoller et al.
JOURNAL OF CHROMATOGRAPHY A (2000)
分享论文
